The inhibition of FABP4 can improve type 2 diabetes mellitus and atherosclerosis in mouse model, and elevated circulating FABP4 levels are associated with obesity, metabolic disease, and cardiac dysfunction in humans [12]. The gene discussed is FABP4; the disease is type 2 diabetes mellitus.